The evaluation of inflammatory and oxidative stress biomarkers on coffee-diabetes association: Results from the 10-year follow-up of the ATTICA Study (2002-2012)

European Journal of Clinical Nutrition

Volumn 69, Issue 11, 2015, Pages 1220-1225

  Koloverou, E ^a   Panagiotakos, D B ^a   Pitsavos, C ^b   Chrysohoou, C ^b   Georgousopoulou, E N ^a   Laskaris, A ^a   Stefanadis, C ^b  

^a HAROKOPIO UNIVERSITY   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER; COFFEE; PLANT EXTRACT; SERUM AMYLOID A;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COFFEE; DIABETES MELLITUS; DRINKING BEHAVIOR; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; VERY ELDERLY; WAIST CIRCUMFERENCE; ADOLESCENT; ADVERSE EFFECTS; BLOOD; CHEMISTRY; DIABETES MELLITUS, TYPE 2; DIET; FEEDING BEHAVIOR; FOLLOW UP; GREECE; INFLAMMATION; LIFESTYLE; METABOLISM; MIDDLE AGED; PATHOLOGY; QUESTIONNAIRE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; COFFEE; DIABETES MELLITUS, TYPE 2; DIET; FEMALE; FOLLOW-UP STUDIES; FOOD HABITS; GREECE; HUMANS; INCIDENCE; INFLAMMATION; LIFE STYLE; MALE; MIDDLE AGED; OXIDATIVE STRESS; PLANT EXTRACTS; RISK FACTORS; SERUM AMYLOID A PROTEIN; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84947031440     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2015.98     Document Type: Article

References (33)

1. International Diabetes Federation. IDF Diabetes Atlas, 6th edn. Brussels, 2013.
2. Mursu J, Virtanen JK, Tuomainen TP, Nurmi T, Voutilainen S. Intake of fruit, berries, and vegetables and risk of type 2 diabetes in Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr 2014; 99: 328-333.
3. Panagiotakos DB, Pitsavos C, Chrysohoou C, Kokkinos P, Toutouzas P, Stefanadis C. The J-shaped effect of coffee consumption on the risk of developing acute coronary syndromes: the CARDIO2000 case-control study. J Nutr 2003; 133: 3228-3232.
4. Vlachopoulos C, Panagiotakos D, Ioakeimidis N, Dima I, Stefanadis C. Chronic coffee consumption has a detrimental effect on aortic stiffness and wave reflections. Am J Clin Nutr 2005; 81: 1307-1312.
5. van Dam RM, Feskens EJ. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2002; 360: 1477-1478.
6. Boggs DA, Rosenberg L, Ruiz-Narvaez EA, Palmer JR. Coffee, tea, and alcohol intake in relation to risk of type 2 diabetes in African American women. Am J Clin Nutr 2010; 92: 960-966.
7. Saremi A, Tulloch-Reid M, Knowler WC. Coffee consumption and the incidence of type 2 diabetes. Diabetes Care 2003; 26: 2211-2212.
8. Reunanen A, Heliovaara M, Aho K. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2003; 361: 702-703.
9. van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005; 294: 97-104.
10. Jiang X, Zhang D, Jiang W. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr 2013; 53: 25-38.
11. Akash MS, Rehman K, Chen S. Effects of coffee on type 2 diabetes mellitus. Nutrition 2014; 30: 755-763.
12. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003; 52: 1-8.
13. Anderson RA, Roussel AM, Zouari N, Mahjoub S, Matheau JM, Kerkeni A. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr 2001; 20: 212-218.
14. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11: 98-107.
15. Donath MY, Mandrup-Poulsen T. The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus. Nat Clin Pract Endocrinol Metab 2008; 4: 240-241.
16. Natella F, Nardini M, Giannetti I, Dattilo C, Scaccini C. Coffee drinking influences plasma antioxidant capacity in humans. J Agric Food Chem 2002; 50: 6211-6216.
17. Kempf K, Herder C, Erlund I, Kolb H, Martin S, Carstensen M et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr 2010; 91: 950-957.
18. Jacobs S, Kroger J, Floegel A, Boeing H, Drogan D, Pischon T et al. Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study. Am J Clin Nutr 2014; 100: 891-900.
19. Pitsavos C, Panagiotakos DB, Chrysohoou C, Stefanadis C. Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study. BMC Public Health 2003; 3: 32.
20. Papathanasiou G, Georgoudis G, Papandreou M, Spyropoulos P, Georgakopoulos D, Kalfakakou V et al. Reliability measures of the short International Physical Activity Questionnaire (IPAQ) in Greek young adults. Hellenic J Cardiol 2009; 50: 283-294.
21. Katsouyanni K, Rimm EB, Gnardellis C, Trichopoulos D, Polychronopoulos E, Trichopoulou A. Reproducibility and relative validity of an extensive semi-quantitative food frequency questionnaire using dietary records and biochemical markers among Greek schoolteachers. Int J Epidemiol 1997; 26 (Suppl 1): S118-S127.
22. Panagiotakos DB, Pitsavos C, Stefanadis C. Dietary patterns: a Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk. Nutr Metab Cardiovasc Dis 2006; 16: 559-568.
23. Bunker ML, McWilliams M. Caffeine content of common beverages. J Am Diet Assoc 1979; 74: 28-32.
24. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
25. Koloverou E, Panagiotakos D, Pitsavos C, Chrysohoou C, Georgousopoulou E, Pitaraki E et al. 10-year incidence of diabetes and associated risk factors in Greece: the ATTICA study (2002-2012). Rev Diabet Stud 2014; 11: 181-189.
26. Carlsson S, Hammar N, Grill V, Kaprio J. Coffee consumption and risk of type 2 diabetes in Finnish twins. Int J Epidemiol 2004; 33: 616-617.
27. Kotani K, Tsuzaki K, Sano Y, Maekawa M, Fujiwara S, Hamada T et al. The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population. Clin Chem Lab Med 2008; 46: 1434-1437.
28. Lopez-Garcia E, van Dam RM, Qi L, Hu FB. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 2006; 84: 888-893.
29. Yamashita K, Yatsuya H, Muramatsu T, Toyoshima H, Murohara T, Tamakoshi K. Association of coffee consumption with serum adiponectin, leptin, inflammation and metabolic markers in Japanese workers: a cross-sectional study. Nutr Diabetes 2012; 2: e33.
30. Pham NM, Wang Z, Morita M, Ohnaka K, Adachi M, Kawate H et al. Combined effects of coffee consumption and serum gamma-glutamyltransferase on serum C-reactive protein in middle-aged and elderly Japanese men and women. Clin Chem Lab Med 2011; 49: 1661-1667.
31. Marzi C, Huth C, Herder C, Baumert J, Thorand B, Rathmann W et al. Acute-phase serum amyloid A protein and its implication in the development of type 2 diabetes in the KORA S4/F4 study. Diabetes Care 2013; 36: 1321-1326.
32. Montonen J, Knekt P, Jarvinen R, Reunanen A. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 2004; 27: 362-366.
33. Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997; 26 (Suppl 1): S59-S70.